✦ LIBER ✦

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma

✍ Scribed by Yi-Fu He; Yu-Hong Li; Feng-Hua Wang; Wen-Qi Jiang; Rui-Hua Xu; Xiao-Fei Sun; Zhong-Jun Xia; Hui-Qiang Huang; Tong-Yu Lin; Li Zhang; Shi-Ping Bao; You-Jian He; Zhong-zhen Guan

Book ID: 105989100
Publisher: Springer
Year: 2008
Tongue: English
Weight: 105 KB
Volume: 87
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-008-0454-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of entecavir and lamivudine i

Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy

✍ H.-R. Li; J.-J. Huang; H.-Q. Guo; X. Zhang; Y. Xie; H.-L. Zhu; L.-Z. Zhai; X.-X. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Delayed hepatitis B virus reactivation a

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP

✍ Ming-Shen Dai; Tsu-Yi Chao; Woei-Yau Kao; Rong-Yaun Shyu; Tan-Mei Liu 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 187 KB

Reactivation of hepatitis B virus after

Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma

✍ Kosei Matsue; Shun-Ichi Kimura; Yoko Takanashi; Kan-Ichi Iwama; Hideaki Fujiwara 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Possible efficacy of lamivudine treatmen

Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma

✍ Y. Tsutsumi; J. Tanaka; T. Kawamura; T. Miura; H. Kanamori; S. Obara; M. Asaka; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 106 KB

Preemptive use of interferon or lamivudi

Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy

✍ ShiangJiin Leaw; ChiaJui Yen; WenTsung Huang; TsaiYun Chen; WuChou Su; ChaoJung 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 139 KB

A revisit of prophylactic lamivudine for

A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

✍ Chiun Hsu; Chao A. Hsiung; Ih-Jen Su; Wei-Shou Hwang; Ming-Chung Wang; Sheng-Fun 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

Lamivudine is effective to control hepatitis B virus (HBV) reactivation in HBV-carrying cancer patients who undergo chemotherapy, but the optimal treatment protocol remains undetermined. In this study, HBV carriers with newly diagnosed non-Hodgkin's lymphoma (NHL) who underwent chemotherapy were ran